OS7.3 Health-related quality of life (HRQoL) evaluation in the REGOMA trial: a randomized, phase II clinical trial analyzing regorafenib activity in relapsed glioblastoma patients
Lombardi, G; Del Bianco, P; Brandes, A; Eoli, M; Rudà, R; Ibrahim, T; Lolli, I; Pace, A; Daniele, B; Pasqualetti, F; Rizzato, S; Bergo, E; Caccese, M; Padovan, M; Soffietti, R; De Salvo, G; Zagonel, V
- 期刊名称Neuro-Oncology
- 作者Lombardi, G; Del Bianco, P; Brandes, A; Eoli, M; Rudà, R; Ibrahim, T; Lolli, I; Pace, A; Daniele, B; Pasqualetti, F; Rizzato, S; Bergo, E; Caccese, M; Padovan, M; Soffietti, R; De Salvo, G; Zagonel, V
- 卷第21卷
- 印刷ISSN1522-8517
- 电子ISSN1523-5866
- 文件大小93.18KB
- 发表时间2019-09-06
- DOI10.1093/neuonc/noz126.046